Skip to main content

An integrated risk model stratifying seizure risk following brain tumor resection among seizure-naive patients without antiepileptic prophylaxis.

Publication ,  Journal Article
Jin, MC; Parker, JJ; Prolo, LM; Wu, A; Halpern, CH; Li, G; Ratliff, JK; Han, SS; Skirboll, SL; Grant, GA
Published in: Neurosurg Focus
April 2022

OBJECTIVE: The natural history of seizure risk after brain tumor resection is not well understood. Identifying seizure-naive patients at highest risk for postoperative seizure events remains a clinical need. In this study, the authors sought to develop a predictive modeling strategy for anticipating postcraniotomy seizures after brain tumor resection. METHODS: The IBM Watson Health MarketScan Claims Database was canvassed for antiepileptic drug (AED)- and seizure-naive patients who underwent brain tumor resection (2007-2016). The primary event of interest was short-term seizure risk (within 90 days postdischarge). The secondary event of interest was long-term seizure risk during the follow-up period. To model early-onset and long-term postdischarge seizure risk, a penalized logistic regression classifier and multivariable Cox regression model, respectively, were built, which integrated patient-, tumor-, and hospitalization-specific features. To compare empirical seizure rates, equally sized cohort tertiles were created and labeled as low risk, medium risk, and high risk. RESULTS: Of 5470 patients, 983 (18.0%) had a postdischarge-coded seizure event. The integrated binary classification approach for predicting early-onset seizures outperformed models using feature subsets (area under the curve [AUC] = 0.751, hospitalization features only AUC = 0.667, patient features only AUC = 0.603, and tumor features only AUC = 0.694). Held-out validation patient cases that were predicted by the integrated model to have elevated short-term risk more frequently developed seizures within 90 days of discharge (24.1% high risk vs 3.8% low risk, p < 0.001). Compared with those in the low-risk tertile by the long-term seizure risk model, patients in the medium-risk and high-risk tertiles had 2.13 (95% CI 1.45-3.11) and 6.24 (95% CI 4.40-8.84) times higher long-term risk for postdischarge seizures. Only patients predicted as high risk developed status epilepticus within 90 days of discharge (1.7% high risk vs 0% low risk, p = 0.003). CONCLUSIONS: The authors have presented a risk-stratified model that accurately predicted short- and long-term seizure risk in patients who underwent brain tumor resection, which may be used to stratify future study of postoperative AED prophylaxis in highest-risk patient subpopulations.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neurosurg Focus

DOI

EISSN

1092-0684

Publication Date

April 2022

Volume

52

Issue

4

Start / End Page

E3

Location

United States

Related Subject Headings

  • Seizures
  • Retrospective Studies
  • Patient Discharge
  • Neurology & Neurosurgery
  • Humans
  • Brain Neoplasms
  • Anticonvulsants
  • Aftercare
  • 3209 Neurosciences
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jin, M. C., Parker, J. J., Prolo, L. M., Wu, A., Halpern, C. H., Li, G., … Grant, G. A. (2022). An integrated risk model stratifying seizure risk following brain tumor resection among seizure-naive patients without antiepileptic prophylaxis. Neurosurg Focus, 52(4), E3. https://doi.org/10.3171/2022.1.FOCUS21751
Jin, Michael C., Jonathon J. Parker, Laura M. Prolo, Adela Wu, Casey H. Halpern, Gordon Li, John K. Ratliff, Summer S. Han, Stephen L. Skirboll, and Gerald A. Grant. “An integrated risk model stratifying seizure risk following brain tumor resection among seizure-naive patients without antiepileptic prophylaxis.Neurosurg Focus 52, no. 4 (April 2022): E3. https://doi.org/10.3171/2022.1.FOCUS21751.
Jin, Michael C., et al. “An integrated risk model stratifying seizure risk following brain tumor resection among seizure-naive patients without antiepileptic prophylaxis.Neurosurg Focus, vol. 52, no. 4, Apr. 2022, p. E3. Pubmed, doi:10.3171/2022.1.FOCUS21751.
Jin MC, Parker JJ, Prolo LM, Wu A, Halpern CH, Li G, Ratliff JK, Han SS, Skirboll SL, Grant GA. An integrated risk model stratifying seizure risk following brain tumor resection among seizure-naive patients without antiepileptic prophylaxis. Neurosurg Focus. 2022 Apr;52(4):E3.

Published In

Neurosurg Focus

DOI

EISSN

1092-0684

Publication Date

April 2022

Volume

52

Issue

4

Start / End Page

E3

Location

United States

Related Subject Headings

  • Seizures
  • Retrospective Studies
  • Patient Discharge
  • Neurology & Neurosurgery
  • Humans
  • Brain Neoplasms
  • Anticonvulsants
  • Aftercare
  • 3209 Neurosciences
  • 1109 Neurosciences